S1PR1 and Parkinson disease: Several lines of studies have suggested reduced expression of S1PR1 in PD-like conditions, and it has been suggested that pharmacological agonists of S1PR1 are responsible for significant regulation of PD-associated neuroinflammation and neurodegeneration [7,17].